These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1679193)

  • 21. Inhibition of tyrosine aminotransferase gene expression by retinoic acid.
    Pan CJ; Shelly LL; Rabin DS; Chou JY
    Mol Endocrinol; 1992 Apr; 6(4):572-80. PubMed ID: 1350056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells.
    Simons SS; Mercier L; Miller NR; Miller PA; Oshima H; Sistare FD; Thompson EB; Wasner G; Yen PM
    Cancer Res; 1989 Apr; 49(8 Suppl):2244s-2252s. PubMed ID: 2564808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements.
    Nitsch D; Boshart M; Schütz G
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5479-83. PubMed ID: 8100067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells.
    Crettaz M; Muller-Wieland D; Kahn CR
    Biochemistry; 1988 Jan; 27(1):495-500. PubMed ID: 2894848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-mediated regulation of tyrosine aminotransferase in rat hepatoma cells: inhibition of transcription and inhibition of enzyme degradation.
    Moore PS; Koontz JW
    Arch Biochem Biophys; 1989 Dec; 275(2):486-95. PubMed ID: 2574563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of steroid-inducible tyrosine aminotransferase gene expression by N-methyl-N'-nitro-N-nitrosoguanidine in a rat hepatoma cell line.
    Miller MS; Wogan GN
    Carcinogenesis; 1986 Aug; 7(8):1273-8. PubMed ID: 2873903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive and negative regulation of a transfected chimeric tyrosine aminotransferase gene: effect of copy number.
    Grange T; Roux J; Fromont-Racine M; Pictet R
    Exp Cell Res; 1989 Jan; 180(1):220-33. PubMed ID: 2562829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of N-methyl-N'-nitro-N-nitrosoguanidine on constitutive and hormone-inducible gene expression in rat hepatoma cells.
    Miller MS
    Chem Biol Interact; 1990; 73(2-3):207-19. PubMed ID: 1690087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal activation of a tyrosine aminotransferase fusion gene does not occur in albino lethal mice.
    Beermann F; Hummler E; Schmid E; Schütz G
    Mech Dev; 1993 Jul; 42(1-2):59-65. PubMed ID: 8103668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-mediated inhibition of the induction of tyrosine aminotransferase by dexamethasone.
    Cheatham B; Carmichael D; Peterson R; Pan L; Koontz JW
    Arch Biochem Biophys; 1992 Nov; 298(2):522-6. PubMed ID: 1358029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-specific DNaseI hypersensitive sites in the 5'-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes.
    Becker P; Renkawitz R; Schütz G
    EMBO J; 1984 Sep; 3(9):2015-20. PubMed ID: 6149120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid-induced DNA demethylation and gene memory during development.
    Thomassin H; Flavin M; Espinás ML; Grange T
    EMBO J; 2001 Apr; 20(8):1974-83. PubMed ID: 11296230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tyrosine aminotransferase glucocorticoid response element also mediates androgen enhancement of gene expression.
    Denison SH; Sands A; Tindall DJ
    Endocrinology; 1989 Feb; 124(2):1091-3. PubMed ID: 2563241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of insulin action using differentiated and dedifferentiated hepatoma cells.
    Crettaz M; Kahn CR
    Endocrinology; 1983 Oct; 113(4):1201-9. PubMed ID: 6137358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of tyrosine aminotransferase by insulin and cyclic AMP: similar effects on activity but opposite effects on transcription.
    Moore PS; Koontz JW
    Mol Endocrinol; 1989 Nov; 3(11):1724-32. PubMed ID: 2575213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal assignment and trans regulation of the tyrosine aminotransferase structural gene in hepatoma hybrid cells.
    Peterson TC; Killary AM; Fournier RE
    Mol Cell Biol; 1985 Sep; 5(9):2491-4. PubMed ID: 2874483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells.
    Carr KD; Richard-Foy H
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9300-4. PubMed ID: 1979170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of TAT gene induction by glucocorticoids involves a neutralizing sequence.
    Jackson DA; Collier CD; Oshima H; Simons SS
    J Steroid Biochem Mol Biol; 1998 Aug; 66(3):79-91. PubMed ID: 9719442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse correlation between dexamethasone 21-mesylate agonist activity and sensitivity to dexamethasone for induction of tyrosine aminotransferase in rat hepatoma cells.
    Simons SS; Miller PA; Wasner G; Miller NR; Mercier L
    J Steroid Biochem; 1988 Jul; 31(1):1-7. PubMed ID: 2899655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors.
    Becker PB; Ruppert S; Schütz G
    Cell; 1987 Nov; 51(3):435-43. PubMed ID: 2889531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.